TrialAmerican journal of nephrology2018

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.

Melanie P Chin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.